We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Report: Top Drugmakers Put Tax Savings Toward Stock Buybacks Not Lower Prices
Report: Top Drugmakers Put Tax Savings Toward Stock Buybacks Not Lower Prices
None of the 10 largest U.S. drugmakers have lowered prescription drug prices as a result of the tax reform passed in 2017, according to an analysis from the office of Sen. Cory Booker (D-N.J.).